Conquer Aging: Predicting Heart Disease Risk With ApoB, LP(a), and VLDL

🟢
Peer-Reviewed Research
C
Conquer Aging

Video Summary · March 15, 2026

View Full Protocol →

Key Takeaways

  • Test ApoB levels to accurately assess heart disease risk, as it measures the number of atherogenic particles.
  • Monitor LP(a) levels, as elevated levels significantly increase cardiovascular risk.
  • Track VLDL particles to understand triglyceride-rich lipoprotein contribution to heart disease.
  • Combine lipid panel with these markers for a comprehensive heart disease risk assessment.

Bottom Line

Include ApoB, LP(a), and VLDL testing in your routine lipid panel to better predict and manage your heart disease risk.

Explore More

Watch the Full Video

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚡ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

From Our Research Network

Part of the Evidence-Based Research Network

Similar Posts